Showing results (1-10 of 229) with videos related to
Sort By:
Pageof 23
Molecular Endocrinology (Baltimore, Md.)|March 30, 2002
Evaluation of ligand-dependent changes in AR structure using peptide probesChing-Yi Chang, Donald P McDonnellTrends in Pharmacological Sciences|April 30, 2005
Androgen receptor-cofactor interactions as targets for new drug discoveryChing-yi Chang, Donald P McDonnellClinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 29, 2012
Molecular pathways: the metabolic regulator estrogen-related receptor α as a therapeutic target in cancerChing-yi Chang, Donald P McDonnellEndocrine Reviews|May 9, 2025
The Roles of Natural Killer Cells in Breast Cancer Pathobiology and their Regulation by EstrogensJovita Byemerwa, Ching-Yi Chang, Donald P McDonnellTrends in Endocrinology and Metabolism: TEM|November 28, 2022
Eosinophilia in cancer and its regulation by sex hormonesSandeep Artham, Ching-Yi Chang, Donald P McDonnellCancer Cell|February 14, 2018
Neomorphic ERα Mutations Drive Progression in Breast Cancer and Present a Challenge for New Drug DiscoveryDonald P McDonnell, John D Norris, Ching-Yi ChangTrends in Endocrinology and Metabolism: TEM|December 3, 2014
Cholesterol and breast cancer pathophysiologyErik R Nelson, Ching-yi Chang, Donald P McDonnellMolecular Endocrinology (Baltimore, Md.)|July 30, 2005
Development of peptide antagonists for the androgen receptor using combinatorial peptide phage displayChing-Yi Chang, Jennifer Abdo, Tanya Hartney, et al.The American Journal of Cardiology|July 11, 2002
Elucidation of the molecular mechanism of action of selective estrogen receptor modulatorsDonald P McDonnell, Ashini Wijayaratne, Ching-yi Chang, et al.Bioorganic & Medicinal Chemistry|December 24, 2013
4,4'-Unsymmetrically substituted 3,3'-biphenyl alpha helical proteomimetics as potential coactivator binding inhibitorsPatrick T Weiser, Ching-Yi Chang, Donald P McDonnell, et al.Pageof 23